Literature DB >> 3444800

Cyclosporin A in steroid-sensitive nephrotic syndrome with frequent relapses.

M K Chan1, I K Cheng.   

Abstract

Eight patients with steroid-sensitive nephrotic syndrome which frequently relapsed despite cyclophosphamide treatment were given cyclosporin A (7.5 mg/kg/day to 10 mg/kg/day) for 8 to 12 weeks. Six had minimal change glomerulonephritis and two had focal segmental glomerulonephritis. Cyclosporin A was given to 5 patients when their nephrotic syndrome was in relapse and to 3 patients when the nephrotic syndrome was in remission. Cyclosporin A induced a transient remission in only one patient.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3444800      PMCID: PMC2428548          DOI: 10.1136/pgmj.63.743.757

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  10 in total

1.  Remission of idiopathic nephrotic syndrome after treatment with cyclosporin A.

Authors:  A Meyrier; P Simon; G Perret; M C Condamin-Meyrier
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-22

2.  Cyclosporin in frequently relapsing minimal change nephrotic syndrome.

Authors:  P F Hoyer; F Krull; J Brodehl
Journal:  Lancet       Date:  1986-08-09       Impact factor: 79.321

3.  Cyclosporin and idiopathic nephrotic syndrome.

Authors:  C Lagrue; J Laurent; D Belghiti; R Robeva
Journal:  Lancet       Date:  1986-09-20       Impact factor: 79.321

4.  Recurrence of nephrotic syndrome during cyclosporin treatment after renal transplantation.

Authors:  A J Voets; A J Hoitsma; R A Koene
Journal:  Lancet       Date:  1986-02-01       Impact factor: 79.321

5.  Pathogenesis of lipoid nephrosis: a disorder of T-cell function.

Authors:  R J Shalhoub
Journal:  Lancet       Date:  1974-09-07       Impact factor: 79.321

6.  Cyclosporin A in nephrotic syndrome of childhood--a 14 month experience.

Authors:  G Capodicasa; N G De Santo; F Nuzzi; C Giordano
Journal:  Int J Pediatr Nephrol       Date:  1986 Apr-Jun

7.  Impaired cell-mediated immunity in lipoid nephrosis.

Authors:  K Matsumoto; K Osakabe; M Harada; M Hatano
Journal:  Nephron       Date:  1981       Impact factor: 2.847

8.  Steroid-responsive and nephrotic syndrome and allergy: clinical studies.

Authors:  S R Meadow; J K Sarsfield
Journal:  Arch Dis Child       Date:  1981-07       Impact factor: 3.791

9.  Cyclosporin A-induced suppression of ongoing IgE antibody formation in the mouse.

Authors:  H Okudaira; Y Sakurai; K Terada; E Terada; T Ogita; T Miyamoto
Journal:  Int Arch Allergy Appl Immunol       Date:  1986

10.  Effect of cyclosporin A on antibody-induced experimental glomerulonephritis.

Authors:  P G Tipping; S R Holdsworth
Journal:  Nephron       Date:  1985       Impact factor: 2.847

  10 in total
  2 in total

Review 1.  The use of cyclosporin A in adult nephrotic syndrome: nine cases and literature review.

Authors:  A Green; Y O'Meara; J Sheehan; M Carmody; G Doyle; J Donohoe
Journal:  Ir J Med Sci       Date:  1990-06       Impact factor: 1.568

Review 2.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.